Potassium Citrate Tablet
Product Images NDC 44523-415

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 44523-415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocomp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bcp 12610 L41501r0521 Potassium Citrate 15 Meq 100ct Label Fnl1 Vp

Potassium Citrate extended-release tablet, 15 mEq (1620 mg) per tablet, oral dosage form, in a package of 100 tablets. The label displays NDC 44523-415-01, indicates Rx only, and shows the BioComp Pharma, Inc. logo and manufacturer information. The label is primarily white with a prominent blue banner behind the product name.*

FDA Label Image

Table

A data table presenting clinical outcome statistics grouped by sample size (n) related to the formation of stones per year in baseline and treatment phases, showing remission and decrease percentages across four patient groups.*

FDA Label Image

Structure Of Potassium Citrate (Potassium Citrate Structure)

Chemical structure of potassium citrate showing the central carbon with three carboxylate groups (COOK) and a hydroxyl group (HO), combined with one water molecule (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.